Jenburkt [JENBURPH] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Jenburkt Pharmaceuticals Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Jenburkt Pharmaceuticals Ltd. wins in 15 metrics, Innova Captab Ltd. wins in 5 metrics, with 0 ties. Jenburkt Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Jenburkt Pharmaceuticals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 14.42 31.20 Jenburkt Pharmaceuticals Ltd.
Price-to-Book Ratio 2.56 4.05 Jenburkt Pharmaceuticals Ltd.
Debt-to-Equity Ratio 0.93 32.95 Jenburkt Pharmaceuticals Ltd.
PEG Ratio -0.38 1.33 Innova Captab Ltd.
EV/EBITDA 11.57 20.49 Jenburkt Pharmaceuticals Ltd.
Profit Margin (TTM) 19.63% 8.85% Jenburkt Pharmaceuticals Ltd.
Operating Margin (TTM) 15.33% 12.88% Jenburkt Pharmaceuticals Ltd.
EBITDA Margin (TTM) 15.33% 12.88% Jenburkt Pharmaceuticals Ltd.
Return on Equity 18.66% 13.37% Jenburkt Pharmaceuticals Ltd.
Return on Assets (TTM) 16.34% 8.12% Jenburkt Pharmaceuticals Ltd.
Free Cash Flow (TTM) $81.92M $-1.09B Jenburkt Pharmaceuticals Ltd.
Dividend Yield 2.48% 0.30% Jenburkt Pharmaceuticals Ltd.
1-Year Return -10.00% 3.87% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 2.83 2.76 Innova Captab Ltd.
Enterprise Value $4.59B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.78 2.90 Jenburkt Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 79.57% 35.19% Jenburkt Pharmaceuticals Ltd.
Revenue per Share (TTM) $374 $262 Jenburkt Pharmaceuticals Ltd.
Earnings per Share (Diluted) $73.50 $23.16 Jenburkt Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.33 -0.33 Innova Captab Ltd.

Jenburkt Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

JENBURPH
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Jenburkt Pharmaceuticals Ltd.-1.09%1.28%-2.09%15.56%6.36%6.69%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Jenburkt Pharmaceuticals Ltd.-10.00%65.07%145.34%194.80%1,213.55%5,074.07%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Jenburkt Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricJENBURPHINNOVACAP
Market Information
Market Cap i₹4.68B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,043578,151
90 Day Avg. Volume i1,047217,693
Last Close₹1,174.55₹947.95
52 Week Range₹944.00 - ₹1,410.00₹622.00 - ₹978.00
% from 52W High-16.70%-3.07%
All-Time High₹1,410.00 (Jul 08, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-16.70%-24.77%
Growth Metrics
Quarterly Revenue Growth0.17%0.42%
Quarterly Earnings Growth-0.09%0.23%
Financial Health
Profit Margin (TTM) i0.20%0.09%
Operating Margin (TTM) i0.15%0.13%
Return on Equity (TTM) i0.19%0.13%
Debt to Equity (MRQ) i0.9332.95
Cash & Liquidity
Book Value per Share (MRQ)₹414.40₹178.28
Cash per Share (MRQ)₹21.86₹10.22
Operating Cash Flow (TTM) i₹252.79M₹282.88M
Levered Free Cash Flow (TTM) i₹320.61M₹1.28B
Dividends
Last 12-Month Dividend Yield i2.48%0.30%
Last 12-Month Dividend i₹33.30₹2.00

Valuation & Enterprise Metrics Analysis: Jenburkt Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricJENBURPH (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.4231.20
Forward P/E i30.4121.90
PEG Ratio i-0.381.33
Price to Sales (TTM) i2.832.76
Price to Book (MRQ) i2.564.05
Market Capitalization
Market Capitalization i₹4.68B₹41.43B
Enterprise Value i₹4.59B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.782.90
Enterprise to EBITDA i11.5720.49
Risk & Other Metrics
Beta i0.33-0.33
Book Value per Share (MRQ) i₹414.40₹178.28

Financial Statements Comparison: Jenburkt Pharmaceuticals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricJENBURPH (2025)INNOVACAP (2025)
Revenue/Sales i1.51B12.34B
Cost of Goods Sold i308.14M8.38B
COGS % of Revenue i20.4%67.9%
Gross Profit i1.21B3.96B
Gross Margin i79.6%32.1%
Research & Development i4.34MN/A
Operating Income (EBIT) i376.79M1.65B
Operating Margin i24.9%13.4%
EBITDA i461.81M2.00B
EBITDA Margin i30.5%16.2%
Pre-Tax Income i439.33M1.71B
Pre-Tax Income % of Revenue i29.0%13.9%
Income Tax i118.72M427.58M
Income Tax % of Revenue i7.8%3.5%
Net Income (Profit) i320.61M1.28B
Profit Margin i21.2%10.4%

Balance Sheet & Liquidity Metrics

MetricJENBURPH (2025)INNOVACAP (2025)
Cash & Equivalents i73.65M155.19M
Total Current Assets i565.32M7.03B
Total Current Assets % of Revenue i37.3%57.0%
Total Current Liabilities i188.19M3.53B
Total Current Liabilities % of Revenue i12.4%28.6%
Long-Term Debt i14.92M2.45B
Long-Term Debt % of Revenue i1.0%19.8%
Total Shareholders Equity i1.72B9.59B
Retained Earnings i1.62B4.53B
Retained Earnings % of Revenue i107.3%36.7%
Property, Plant & Equipment i144.29M442.93M

Cash Flow Statement Comparison

MetricJENBURPH (2025)INNOVACAP (2025)
Operating Cash Flow i252.79M282.88M
Operating Cash Flow % of Revenue i16.7%2.3%
Capital Expenditures i-197.14M-1.72B
Free Cash Flow i81.92M-1.09B
FCF Margin i5.4%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricJENBURPHINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i4.41M57.22M
Float Shares i1.26M15.91M
% Held by Insiders i63.59%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i36.41%8.59%

Dividend Analysis & Yield Comparison: Jenburkt Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricJENBURPHINNOVACAP
Last 12-Month Dividend i₹33.30₹2.00
Last 12-Month Dividend Yield i2.48%0.30%
3-Year Avg Annual Dividend i₹19.90₹0.67
3-Year Avg Dividend Yield i1.83%0.30%
3-Year Total Dividends i₹59.70₹2.00
Ex-Dividend DateJul 11, 2025Jan 30, 2026